Effects of immunomodulation in classic infantile Pompe patients with high antibody titers

Poelman, E.; Hoogeveen-Westerveld, M.; Hout, J.M.P. van den; Bredius, R.G.M.; Lankester, A.C.; Driessen, G.J.A.; ... ; Ploeg, A.T. van der (2019)

Article / Letter to editor

• Pompe disease
• ERT
• Antibodies
• Immunomodulation
• Bortezomib
• Cross-reactive immunologic material (CRIM)

• All authors: Poelman, E.; Hoogeveen-Westerveld, M.; Hout, J.M.P. van den; Bredius, R.G.M.; Lankester, A.C.; Driessen, G.J.A.; Kamphuis, S.S.M.; Pijnappel, W.W.M.; Ploeg, A.T. van der
• Date: 2019-03-22
• Journal: Orphanet Journal of Rare Diseases
• Volume: 14
• DOI: doi:10.1186/s13023-019-1039-z